Bristol-Myers Squibb Company (ETR:BRM)
39.91
-0.09 (-0.23%)
Jun 27, 2025, 5:35 PM CET
Bristol-Myers Squibb Company Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€1,292,458
Profits / Employee
€147,028
Market Cap
82.76B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
Bristol-Myers Squibb Company News
- 1 day ago - U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels - Wallstreet:Online
- 1 day ago - U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels - Benzinga
- 1 day ago - This Once Dominant Dividend Stock May Be About to Come Back to Life in July - 24/7 Wall street
- 3 days ago - Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug - CNBC
- 3 days ago - Cigna files antitrust case against Bristol Myers over Pomalyst sales - Seeking Alpha
- 10 days ago - Bristol Myers Squibb Announces Dividend - Wallstreet:Online
- 12 days ago - Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel) - Wallstreet:Online
- 16 days ago - Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD Agents and BCL6 Ligand-Directed Degrader at EHA 2025 - Wallstreet:Online